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A B S T R A C T
Rapid and reliable screening of SARS-CoV-2 is fundamental to assess viral spread and limit the pandemic we are
facing. In this study, we compared direct rRT-PCR method (without RNA extraction) using SeeGene AllplexTM
2019-nCoV rRT-PCR with the RealStar® SARS-CoV-2 rRT-PCR kit (Altona Diagnostics). Furthermore, we assessed
the impact of swab storage media composition on PCR efficiency. We show that SeeGene and Altona’s assays
provide similar efficiency. Importantly, we provide evidence that RNA extraction can be successfully bypassed
when samples are stored in UTM medium or in molecular water but not when samples are stored in saline
solution and in Hanks medium.
1. Background
Viral detection is key to isolate positive patients and stop viral
transmission [1–6] in our battle against the 2020 SARS-CoV-2 pan-
demic. However, there are many challenges associated with ramping up
testing capacity, including shortage in the chain of supplies for ex-
traction reagents [7]. This situation called for alternative protocols to
ensure the continuity of testing in laboratories.
The standard procedure for testing SARS-CoV-2 from oro-naso-
pharyngeal swabs in the clinical laboratory of the Centre Intégré
Universitaire de Santé et Services Sociaux de la Mauricie et Centre du
Québec (CIUSSS-MCQ) is based on RNA extraction followed by viral
genes detection with a multiplex assay using the Altona RealStar®
SARS-CoV-2 rRT-PCR Kit RUO (thereafter Altona). Due to an increased
demand in SARS-CoV-2 screenings, alternative protocols with similar
sensitivity were needed [8–11]. Thus, we compared the sensitivity of
detection from Health Canada approved SeeGene Allplex™ 2019-nCoV
rRT-QPCR Assay (thereafter SeeGene) and Altona, with and without
RNA extraction. Samples originated from remaining swabs media and
RNA extracts from symptomatic individuals that had been previously
screened using the CIUSS-MCQ routine method. Hence, samples were
declared negative or positive before these experiments.
2. Methods
2.1. Specimens
Swabs from the oro- and naso-pharyngeal area from symptomatic
individuals were placed in 2 ml of UTM (Remel RE12569), or Hanks
medium (0,14 M NaCl; 5 mM KCl, 0,4 mM MgSO4, 0,3 mM Na2HPO4,
0,4 mM KH2PO4, 1 mM CaCl2 and 6 mM glucose from Fisher; and
Phenol Red 1% from Sigma), molecular -grade water (Fisher bior-
eagents), or saline (BioMérieux). Specimens were inactivated at 95 °C
for 5 min and stored at 4 °C.
2.2. Standard operating procedure using RNA extraction and Altona
RNA was extracted using Abbott mSample Preparation Systems DNA
kit on m2000sp instrument (Abbott). rRT-PCR protocol was automated:
prepared on the Abbott m2000sp and detected on the m2000rt using
the Altona kit (Altona diagnostics). Ct values from FAM (E gene), Cy5 (S
gene) and Joe/HEX (internal control) were acquired.
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2.3. Alternative rRT-PCR using SeeGene
SeeGene was performed as per manufacturer’s instruction. Ct from
FAM (E gene), Cal Red 610 (RDRP gene), Quasar 670 (N gene) and HEX
(internal control) were acquired.
Samples were considered positive when a signal was detected at
Ct< 40 for any gene. A sample was considered negative if the internal
control was amplified but not the viral genes. A specimen was con-
sidered invalid when there was no amplification of the internal control.
3. Results and discussion
3.1. Detection of SARS-CoV-2 with SeeGene compared to standard
procedure
RNA stored at −80 °C extracted from 65 SARS-CoV-2-positive and
23 -negative specimens were amplified using SeeGene’s kit. 23 negative
samples were confirmed, 64 out of 65 positive samples were confirmed
positive (96,92 %), one sample detected at Ct = 35.6 (gene S only) with
Altona’s kit was missed using SeeGene’s kit (Fig. 1).
3.2. rRT-PCR directly from swabs: without RNA extraction
The swab storage media for respiratory virus detection can have
important impact on the rRT-PCR efficiency, when this media is used
directly for PCR reaction. To assess the feasibility of direct rRT-PCR
using different media we performed the following experiments.
3.2.1. Detection of SARS-CoV-2 from swabs stored in Hanks medium
95 positive specimens stored in Hanks medium were randomly
chosen for direct rRT-PCR in two separate experiments. 21 (22,3%)
reactions did not show amplification neither of viral genes nor of the
internal control suggesting rRT-PCR inhibition and 69,15% (n = 65)
were positive following analysis (Fig. 2). In comparison, 30 samples in
which the RNA was extracted of 30 tested were positive. Hence, swabs
in Hanks are not appropriate samples for direct rRT-PCR.
3.2.2. Detection of SARS-CoV-2 using direct rRT-PCR from swabs stored in
UTM medium
During this study, some specimens were collected in UTM medium
during routine screening. Seventeen of these swabs tested positive fol-
lowing standard procedure stored at −80 °C, were used for direct rRT-
PCR in two independent experiments. 100 % were detected using
SeeGene and Ct means were equivalent whether or not RNA was ex-
tracted before the rRT-PCR (Fig. 3A). Next, we measured the stability of
the detection in 5 additional samples by amplifying from fresh (stored
at 4 °C), frozen at −80 °C overnight, thawed and stored at 4 °C for 3
days (T0, T24, T48 and T72) (Fig. 3B). Ct values remained constant
across the experiment and all samples could be detected at all time-
points. Our results suggest that UTM medium can be used for direct
rRT-PCR and that storage at 4 °C for a few days before testing does not
lead to a significant loss of detection.
3.2.3. Detection of SARS-CoV-2 from saline or molecular water
Then, we assessed easily available and cheap storage media: saline
and molecular grade water. First, we used extracted and purified RNA
from five positive specimens (Ct between 12,61 and 14,22) that we
diluted using saline or water and used for rRT-PCR. All five samples
were detected by the N target when diluted in saline or in water.
However, when samples were stored in saline, Ct for the N gene were
above 30 compared to a mean of 22 when RNA was diluted in water
following SeeGene. The E gene could not be amplified from saline di-
lutions (Fig. 4a). These results suggest that saline is not compatible with
direct rRT-PCR. We assessed the sensitivity in water and diluted a po-
sitive swab by performing five serial dilutions (each 1:10) from this
Fig. 1. Detection of SARS-CoV-2 with SeeGene compared to standard proce-
dure.
Data are presented as scattered dot plots with means. Each dot represents 1 Ct
value of 65 reactions, each corresponding to a specimen. Purified RNA from 65
SARS-CoV2+ specimens as validated by standard procedure (Altona, S) were
amplified using SeeGene (SeeGene_RNA). The most sensitive targets, i.e. posi-
tive in the highest number of specimens, are shown (S for Altona and N for
SeeGene). The grey dot represents one sample detected at Ct = 35.6 during
standard procedure and missed using SeeGene.
Fig. 2. Detection of SARS-CoV-2 from swabs stored in Hanks medium. Data are
depicted as scattered dot plots with means. Each dot represents 1 Ct value
corresponding to 1 specimen. 94 SARS-CoV2+ specimens as validated by
standard procedure (Altona, S, n = 94) stored in Hanks medium at −80 °C
were used for direct rRT-PCR using SeeGene (No Extr_N, n = 65/94). RNA
isolated from these specimens and stored at −80 °C were separately used as
template for SeeGene rRT-PCR (RNA_N, n = 30/30). The most sensitive target
is shown. 29 positive specimens were not detected by direct rRT-PCR (30,85%).
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swab. These dilutions were also used for RNA extraction and amplifi-
cation using the standard procedure. The undiluted sample and 4 of 5
dilutions showed detectable levels of using N gene and S gene, with
both Altona and SeeGene. Ct values of the E gene and of the N gene
were similar whether RNA was extracted or not, and whether SeeGene
or Altona was used (Fig. 4b).
3.2.4. Detection of SARS-CoV-2 using specimens collected in molecular
water and stored at −80C
Thirty-nine swabs collected in water and stored at −80 °C for one
week, with characterized Ct values (ranging between 16,3 and 39,7)
were used as a template for direct rRT-PCR and for RNA extraction and
amplification, using Altona (Fig. 5A) and SeeGene (Fig. 5B). Twenty-
seven of them could be amplified post-thawing when RNA or swabs
were used with Altona’s multiplex assay. Thirty-two could be detected
from RNA eluates or directly from swabs with SeeGene’s multiplex
assay (Fig. 5b). The initial Ct mean (before freezing) of samples that
were lost following thawing was significantly higher than the Ct mean
of samples that could be amplified (25,7 vs 33,7; p<0.0001; unpaired
t-test) using Altona and SeeGene (25,97 vs 35,68; p<0.0001; unpaired
t-test). This suggests that storing specimens in water at−80°C can lead
to a significant loss in sensitivity for low viral load samples. Direct rRT-
PCR was as efficient as RNA extraction followed by rRT-PCR to detect
positive samples using both methods. In addition, Ct values of the in-
ternal control was significantly higher using direct rRT-PCR compared
to rRT-PCR from purified RNA with Altona (p = 0.0002, paired t-test),
suggesting PCR inhibition when RNA is not purified which was not
observed with SeeGene. From this experiment, we conclude that RNA
Fig. 3. Detection of SARS-CoV-2 using direct rRT-PCR from swabs stored in UTM medium (without RNA extraction). Results are plotted as bar with mean graphs and
scattered dot plots. Each dot represents one reaction corresponding to one specimen. A. Seventeen SARS-CoV-2+ swabs collected and stored in UTM at−80 °C were
randomly chosen and directly amplified (UTM) or amplified from RNA eluates (RNA). ‘n’ stands for the number of SARS-CoV-2+ specimens. Results for all three
targets amplified by SeeGene multiplex assay are shown. The N gene is successfully detected in all the samples. B. Five positive specimens stored in UTM at−80 °C
were randomly chosen, thawed and kept at 4 °C for 3 days. Levels of SARS-CoV-2 RNA was assessed at each time point. All 5 samples were detected by amplification
of the N gene at all timepoint.
Fig. 4. Detection of SARS-CoV-2 in saline or molecular water samples. Results are plotted as bar graphs with standard deviation. A. Each dot represents one reaction
corresponding to one specimen. One hundredth dilution of RNA purified from 5 positive specimens with high Ct values were performed in molecular water and in
saline water. All 5 diluted samples were detected, however, samples diluted in saline water required 10 more Ct before being detected. B. Detection of SARS-CoV-2 by
direct rRT-PCR from swabs stored in molecular water. Each dot represents one reaction corresponding to one dilution of the same specimen that contained RNAse
inhibitor. The specimen collected in water was diluted 5 times following a serial dilution of 1:10 and used for RNA extraction and amplification using the routine
procedure in comparison to SeeGene. Ct values from amplification of extracted RNA from a swab stored in water by standard procedure (Altona_RNA, S and E genes)
and using SeeGene’s kit (SeeGene_RNA; N, RdRP and E genes), or amplified directly from swab and dilutions in water medium (H20; N and E gene) using SeeGene’s
kit are plotted. ‘na’ means ‘not applicable’.
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extraction can be successfully skipped when swabs are collected in
molecular water. However, storing samples at −80 °C collected in
water before screening could impact the sensitivity and a decreased
detection of patients with lower viral loads.
4. Conclusion
Our results suggest that: i) SeeGene and Altona kits provide similar
efficiency, ii) direct rRT-PCR without RNA extraction is possible if
samples are collected in UTM or molecular water; ii), specimens stored
in water should be screened rapidly, iii) RNA extraction is necessary if
samples are in saline water or Hanks medium.
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Fig. 5. Detection of SARS-CoV-2 testing using specimens collected in molecular water stored at −80C. Results are plotted as box and violin graph with range and
histograms of distribution. A. 39 samples with a declared positive status collected and stored in water at−80 °C were used for RNA extraction and amplification, or
for direct amplification using Altona’s kit. Using RNA or directly the wab as a template, 27 were detected post-thawing. Internal control was amplified efficiently
from both types of template, but Ct values were significantly higher when swabs were used as direct templates. 12 samples could not be detected post-thawing. Their
Ct mean before freezing was significantly higher than the Ct mean of samples that could be amplified (25,69 vs 33,7; p<0.0001; unpaired t-test). B. The same 39
positive swabs were used for RNA extraction and amplification or direct amplification using SeeGene’s kit. Using RNA or swabs as templates, 32 were detected post-
thawing. Internal controls were successfully amplified using both RNA and swabs as templates. 7 samples were lost upon thawing and the Ct mean of these samples
before freezing was significantly higher compared to the initial Ct mean of samples that were successfully (25,97 vs 35,68; p<0.0001; unpaired t-test).
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